Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / M••••••••• G•••••

G•••• P•••• Partners II Sells M••••••••• G••••• to C•••••••

Exit to a strategic buyerannouncedannounced Feb 3, 2020Fact
What happened
Target
M••••••••• G•••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • C•••••••Strategic acquirerconfirmed
    “G•••• P•••• Partners II Sells M••••••••• G••••• to C•••••••”
  • N••• R•••••Deal partnerconfirmed
    “N••• R•••••, Managing Director at GPP commented, “We are very proud of what we accomplished with CEO D••••• H•••, President Denis Bedoret, our partners Orgenesis and SFPI-FPIM, and the entire M••••••••• team in just over 18 months.”
  • E•••• H•••••Deal partnerconfirmed
    ““Our theme-based investment approach helped us identify cell and gene therapy manufacturing as a significant growth area and led us to pursue M••••••••• as a platform company in this area,” added E•••• H•••••, Vice President at GPP.”
Sell side
  • G•••• P•••• P•••••••• L••Sellerconfirmed
    “G•••• P•••• Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, is pleased to announce that it has signed a definitive agreement to sell GPP II portfolio company, M••••••••• G••••• (“M•••••••••”), a subsidiary of Orgenesis (NASDAQ: ORGS), to C”
Side not stated
  • D••••• H•••Managementconfirmed
    “GPP’s expertise in growing global pharmaceutical services companies and their extensive network in the industry were integral to our success both times,” commented D••••• H•••, CEO of M•••••••••.”
  • M••••••••• G•••••Targetconfirmed
    “G•••• P•••• Partners II Sells M••••••••• G••••• to C•••••••”
Evidence
“G•••• P•••• Partners II Sells M••••••••• G••••• to C•••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
G•••• P•••• Partners II Sells M••••••••• G••••• to C••••••• | Private Equity Intelligence | DFX